Dermata Therapeutics, Inc. (DRMA) Financials
DRMA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 7.3 million | 916817 |
| 2023-06-30 | 8.7 million | 682862 |
| 2023-03-31 | 9.3 million | 1.2 million |
| 2022-12-31 | 6.9 million | 922634 |
DRMA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -1.8 million | 131177 |
| 2023-06-30 | -1.8 million | 131177 |
| 2023-03-31 | -1.6 million | 131260 |
| 2022-12-31 | -1.8 million | 220890 |
DRMA Net Income
No data available :(
DRMA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 6.6 million | - | - |
| 2023-06-30 | 8.4 million | - | - |
| 2023-03-31 | 8.8 million | - | - |
| 2022-12-31 | 6.2 million | - | - |
DRMA Shares Outstanding
DRMA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 902977 | 909001 | - |
| 2023-06-30 | - | 838931 | 893483 | - |
| 2023-03-31 | - | 1.2 million | 1.1 million | - |
| 2022-12-31 | - | 889355 | 822334 | - |
DRMA Cost of Revenue
No data available :(
DRMA
Price: $0.34
52 week price:
Earnings Per Share: -2.67 USD
P/E Ratio: -0.10
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 329600
Market Capitalization: 2.2 million